Literature DB >> 16378388

Modification of gold nanorods using phosphatidylcholine to reduce cytotoxicity.

Hironobu Takahashi1, Yasuro Niidome, Takuro Niidome, Kenji Kaneko, Hideya Kawasaki, Sunao Yamada.   

Abstract

Hexadecyltrimethylammonium bromide (CTAB), which is necessary for the preparation of gold nanorods (NRs), was extracted from a NR solution into a chloroform phase containing phosphatidylcholine (PC). After three extractions, the zeta potential of the NRs remained positive, but its magnitude decreased from +67 +/- 1 to +15 +/- 1 mV. Transmission electron microscopy and energy-dispersive X-ray analysis indicated that the NRs were passivated with PC. The PC layer on the NR surface contributed to the prevention of NR aggregation. The PC-passivated NRs showed low cytotoxicity in comparison with twice-centrifuged NRs. It was shown that a negligible amount of CTAB was dispersed in the NR solution after the extraction. The extraction using a chloroform phase containing PC was found to be a convenient way of replacing the CTAB with alternative capping agents such as PC. This is a key technique for preparing functional NRs that can have practical applications.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16378388     DOI: 10.1021/la0520029

Source DB:  PubMed          Journal:  Langmuir        ISSN: 0743-7463            Impact factor:   3.882


  63 in total

1.  125I-labeled gold nanorods for targeted imaging of inflammation.

Authors:  Xia Shao; Huanan Zhang; Justin R Rajian; David L Chamberland; Phillip S Sherman; Carole A Quesada; Alisa E Koch; Nicholas A Kotov; Xueding Wang
Journal:  ACS Nano       Date:  2011-10-27       Impact factor: 15.881

2.  Hyperthermic effects of gold nanorods on tumor cells.

Authors:  Terry B Huff; Ling Tong; Yan Zhao; Matthew N Hansen; Ji-Xin Cheng; Alexander Wei
Journal:  Nanomedicine (Lond)       Date:  2007-02       Impact factor: 5.307

3.  Controlling the cellular uptake of gold nanorods.

Authors:  Terry B Huff; Matthew N Hansen; Yan Zhao; Ji-Xin Cheng; Alexander Wei
Journal:  Langmuir       Date:  2007-02-13       Impact factor: 3.882

4.  Evaluation of uptake and distribution of gold nanoparticles in solid tumors.

Authors:  Christopher G England; André M Gobin; Hermann B Frieboes
Journal:  Eur Phys J Plus       Date:  2015-11-19       Impact factor: 3.911

5.  C-reactive protein induced rearrangement of phosphatidylcholine on nanoparticle mimics of lipoprotein particles.

Authors:  Marilyn R Mackiewicz; Heather L Hodges; Scott M Reed
Journal:  J Phys Chem B       Date:  2010-04-29       Impact factor: 2.991

6.  Release kinetics of paclitaxel and cisplatin from two and three layered gold nanoparticles.

Authors:  Christopher G England; M Clarke Miller; Ashani Kuttan; John O Trent; Hermann B Frieboes
Journal:  Eur J Pharm Biopharm       Date:  2015-03-07       Impact factor: 5.571

7.  Synthesis and bioevaluation of ¹²⁵I-labeled gold nanorods.

Authors:  Xia Shao; Ashish Agarwal; Justin R Rajian; Nicholas A Kotov; Xueding Wang
Journal:  Nanotechnology       Date:  2011-02-22       Impact factor: 3.874

8.  Plasmonic nanoparticle-generated photothermal bubbles and their biomedical applications.

Authors:  Dmitri Lapotko
Journal:  Nanomedicine (Lond)       Date:  2009-10       Impact factor: 5.307

9.  Toxicity and cellular uptake of gold nanoparticles: what we have learned so far?

Authors:  Alaaldin M Alkilany; Catherine J Murphy
Journal:  J Nanopart Res       Date:  2010-04-06       Impact factor: 2.253

Review 10.  In vitro assessments of nanomaterial toxicity.

Authors:  Clinton F Jones; David W Grainger
Journal:  Adv Drug Deliv Rev       Date:  2009-04-19       Impact factor: 15.470

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.